Imaging services provider Medical Resources of Hackensack, NJ, got at least a temporary reprieve from NASDAQ for its listing on the stock exchange, the company reported June 2. Medical Resources' NASDAQ listing was in jeopardy due to the company's
Imaging services provider Medical Resources of Hackensack, NJ, got at least a temporary reprieve from NASDAQ for its listing on the stock exchange, the company reported June 2. Medical Resources' NASDAQ listing was in jeopardy due to the company's inability to file its 10-K report with the Securities and Exchange Commission for 1997 financial results. The firm recently filed the report and will be able to maintain its listing, at least for the next several weeks.
NASDAQ set several conditions for the company's continued listing on the exchange. Medical Resources must file its quarterly 10-Q report for its first financial quarter (end-March) by June 12, and by July 24 must meet either NASDAQ's minimum net tangible assets requirement or an alternative requirement that its stock trade at a minimum bid of $5 a share. Medical Resources currently meets neither the tangible assets requirement nor the $5 a share requirement, although the company said it would implement a reverse stock split to meet the latter, if necessary.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.